Difference between revisions of "Pilot Conformance Projects Under Development"

From QIBA Wiki
Jump to: navigation, search
(CT: Lung Tumor Volume (Advanced Disease))
m (QIBA Profile Conformance)
 
(61 intermediate revisions by 3 users not shown)
Line 1: Line 1:
Introductory text regarding the three pilot projects based on self-attestation.
+
{{TOCright}}
  
==CT: Lung Tumor Volume (Advanced Disease)==
+
== <font color=green>'''Self-attestation (Registered) or QIBA Tested (Certified) Opportunities'''</font> ==
Profile
+
<font color=blue>{''This content will eventually be available on the RSNA.org website''.}</font>
Checklist
+
Report Template
+
  
==FDG-PET: Solid Tumor SUV==
+
QIBA Profiles that are at least at the [[QIBA_Profile_Stages#Stage_2:_Consensus|Consensus Stage]] are available to interested parties (clinical sites, CROs, equipment and/or software vendors) to demonstrate that all relevant actors of an institution or product conform to the respective QIBA Profile.
  
==MR: ADC-DW MR Lesions in Four Organs==
+
As shown in the following diagram, QIBA Profile conformance may be demonstrated via Self Attestation, or (when available) via a Certification service:
 +
 
 +
::[[Image:Profile Conformance Image2.jpg|500px]]
 +
 
 +
== <font color=blue>Before starting conformance testing, please </font> [mailto:qiba@rsna.org Email QIBA] ==
 +
 
 +
== <font color=purple>'''QIBA or Designee Testing of Conformance'''</font> ==
 +
 
 +
===CT Small Lung Nodule Volumetry for Screening===
 +
 
 +
*[[Media:QIBA_CT_Vol_SmallLungNoduleAssessmentInCTScreening_2018.11.18-clean-2.pdf|CT Small Lung Nodule Volume Assessment and Monitoring in Low Dose Screening 2018-11-18]]
 +
*https://www.rsna.org/en/research/quantitative-imaging-biomarkers-alliance/qiba-conformance-certification-services
 +
 
 +
 
 +
== <font color=green>'''Self Attestation of Conformance'''</font> ==
 +
 
 +
The following QIBA Profiles have reached the Consensus Stage or the Technically Confirmed Stage, and are thus appropriate for self-attestation conformance testing.
 +
 
 +
===CT: Lung Tumor Volume (Advanced Disease)===
 +
'''Profile'''
 +
* [[Media:QIBA_CTVol_TumorVolumeChangeProfile_TechConfirmed-20180622a.pdf|CT Tumor Volume Change for Advanced Disease (CTV-AD) 2018-06-22]]
 +
'''Checklist'''
 +
* [[Media: QIBA_CTVol_TumorVolumeChangeProfile-Conformance Testing_Checklist_20191111.pdf | CT Conformance Checklist]] (can also refer to Appendix C in the Profile document - pg 42)
 +
* Assessment Procedures (refer to Section 4 in the Profile document - pg 30)
 +
:*[[Media:QIBA_CTVol_TumorVolumeChangeProfile-Conformance Testing_Supplement_2019051111.pdf | CT Conformance Testing Supplement, 2019-11-11]]
 +
'''Report Template'''
 +
:*[[Media:QIBA_Conformance_Statement-Self-Attestation_CTvolAD_20191111-confirmed.pdf | CT Conformance Self - Attestation Document, 2019-11-11]]
 +
 
 +
===FDG-PET: Solid Tumor SUV===
 +
'''Profile'''
 +
* [[Media:QIBA_FDG-PET_Profile_v113.pdf|FDG-PET/CT for Response to Cancer Therapy 2016-11-18]]
 +
'''Checklist'''
 +
* [[Media:QIBA FDG PETCT _Conformance Testing_Checklist_20191111.pdf | QIBA FDG-PET/CT Conformance Testing Checklist, 2019-11-11]]
 +
'''Report Template'''
 +
* [[Media:QIBA_Conformance_Statement-Self-Attestation_FDG-PET_20191811_confirmed.pdf | QIBA FDG-PET/CT Conformance Self - Attestation Document, 2019-11-11]]
 +
 
 +
===DWI MR: ADC of Lesions in Four Organs===
 +
'''Profile'''
 +
*[[Media:QIBADWIProfile_as_of_2019-Feb-05.pdf|Diffusion-Weighted Magnetic Resonance Imaging Profile 2019-02-05]]
 +
'''Checklist'''
 +
*[[Media:QIBA DWI Profile _Conformance Testing_Checklist_20191111.pdf | QIBA DWI-MRI Conformance Checklist, 2019-11-11]]
 +
**[[Media:QIBA DWI Profile _Conformance Testing_Supplement 1_20191111.pdf | QIBA DWI Conformance Testing Supplement #1, 2019-11-11]]
 +
**[[Media:QIBA DWI Profile _Conformance Testing_Supplement 2_20191111.pdf | QIBA DWI Conformance Testing Supplement #2, 2019-11-11]]
 +
'''Report Template'''
 +
*[[Media:QIBA_Conformance_Statement-Self-Attestation_ADC_20191411_confirmed.pdf | QIBA DWI Conformance Self - Attestation Document, 2019-11-11]]

Latest revision as of 17:41, 3 April 2020

Self-attestation (Registered) or QIBA Tested (Certified) Opportunities

{This content will eventually be available on the RSNA.org website.}

QIBA Profiles that are at least at the Consensus Stage are available to interested parties (clinical sites, CROs, equipment and/or software vendors) to demonstrate that all relevant actors of an institution or product conform to the respective QIBA Profile.

As shown in the following diagram, QIBA Profile conformance may be demonstrated via Self Attestation, or (when available) via a Certification service:

Profile Conformance Image2.jpg

Before starting conformance testing, please Email QIBA

QIBA or Designee Testing of Conformance

CT Small Lung Nodule Volumetry for Screening


Self Attestation of Conformance

The following QIBA Profiles have reached the Consensus Stage or the Technically Confirmed Stage, and are thus appropriate for self-attestation conformance testing.

CT: Lung Tumor Volume (Advanced Disease)

Profile

Checklist

  • CT Conformance Checklist (can also refer to Appendix C in the Profile document - pg 42)
  • Assessment Procedures (refer to Section 4 in the Profile document - pg 30)

Report Template

FDG-PET: Solid Tumor SUV

Profile

Checklist

Report Template

DWI MR: ADC of Lesions in Four Organs

Profile

Checklist

Report Template